Thrive Wealth Management LLC Acquires 2,493 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Thrive Wealth Management LLC increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 314.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,286 shares of the medical device company’s stock after acquiring an additional 2,493 shares during the quarter. Thrive Wealth Management LLC’s holdings in Cooper Companies were worth $333,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of COO. Cary Street Partners Investment Advisory LLC acquired a new position in shares of Cooper Companies in the 3rd quarter valued at $26,000. Blue Trust Inc. raised its position in Cooper Companies by 54.8% in the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34 shares in the last quarter. Mather Group LLC. acquired a new position in Cooper Companies in the first quarter worth about $41,000. Lindbrook Capital LLC lifted its stake in Cooper Companies by 182.5% during the fourth quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock worth $43,000 after purchasing an additional 73 shares during the period. Finally, Desjardins Global Asset Management Inc. boosted its holdings in Cooper Companies by 44.8% during the fourth quarter. Desjardins Global Asset Management Inc. now owns 152 shares of the medical device company’s stock valued at $58,000 after purchasing an additional 47 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on COO. TheStreet lowered Cooper Companies from a “b-” rating to a “c” rating in a research report on Thursday, February 29th. Citigroup raised their target price on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Stifel Nicolaus reiterated a “buy” rating and set a $110.00 price target (up previously from $105.00) on shares of Cooper Companies in a research report on Friday, March 1st. Redburn Atlantic upgraded shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price objective for the company in a research report on Tuesday, March 19th. Finally, Piper Sandler boosted their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Friday, March 1st. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average target price of $111.42.

Cooper Companies Stock Down 0.4 %

COO traded down $0.34 during trading on Thursday, hitting $87.62. The company had a trading volume of 1,526,329 shares, compared to its average volume of 1,103,473. The company has a market capitalization of $17.45 billion, a PE ratio of 51.54, a PEG ratio of 2.21 and a beta of 1.02. The company has a quick ratio of 1.14, a current ratio of 1.95 and a debt-to-equity ratio of 0.34. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $104.07. The firm’s 50-day moving average price is $92.79 and its 200 day moving average price is $94.71.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same quarter in the prior year, the firm posted $0.77 EPS. The business’s revenue was up 7.4% on a year-over-year basis. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.